23andme Holding Co share price today

(ME)

23andme Holding Co share price is $4.05 & ₹342.99 as on 7 Dec 2024, 2.30 'hrs' IST

$4.05

▲

0.44

(12.19%)

Market is closed - opens 8 PM, 09 Dec 2024

View live 23andme Holding Co share price in Dollar and Rupees. Guide to invest in 23andme Holding Co from India. Also see the sentimental analysis on Indian investors investing in 23andme Holding Co. Get details on the Indian mutual funds that are investing in 23andme Holding Co. Get Analyst recommendations and forecasts along with all the 23andme Holding Co's financials.

23andme Holding Co share price movements

$3.65
$4.12
$4.05
9.88%
Downside
Day's Volatility :11.36%
Upside
1.65%
$2.66
$20.40
$4.05
34.44%
Downside
52 Weeks Volatility :86.99%
Upside
80.15%

23andme Holding Co Returns

Period	23andme Holding Co	Sector (Health Care)	Index (Russel 2000)
3 Months	-39.83%	-5.7%	0.0%
6 Months	-55.2%	-0.9%	0.0%
1 Year	-78.25%	10.0%	0.0%
3 Years	-97.84%	9.3%	-21.5%

23andme Holding Co Key Statistics

in dollars & INR

Previous Close	$3.61
Open	$3.65
Today's High	$4.118
Today's Low	$3.65
Market Capitalization	$82.0M
Today's Volume	$534.8K
52 Week High	$20.4
52 Week Low	$2.655
Revenue TTM	$199.2M
EBITDA	$-235.1M
Earnings Per Share (EPS)	$-122.52
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-154.21%

How to invest in 23andme Holding Co from India?

It is very easy for Indian residents to invest directly in 23andme Holding Co from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the 23andme Holding Co stock in both rupees (INR) and dollars (USD). Search for 23andme Holding Co or ME on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of 23andme Holding Co or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of 23andme Holding Co shares which would translate to 0.209 fractional shares of 23andme Holding Co as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards 23andme Holding Co

-48%

Period: Sep 8, 2024 to Dec 7, 2024. Change in 30 Days versus previous period

Search volume for 23andme Holding Co on INDmoney from India has reduced in the last 30 days as on Dec 8, 2024. -48% less investors are searching 23andme Holding Co in the last 30 days versus the previous period.

Global Institutional Holdings in 23andme Holding Co

NewView Capital Partners I, LLC
3.72%
Vanguard Group Inc
2.95%
Euclidean Capital LLC
1.96%
Sapphire Ventures (GPE) I, L.L.C.
1.01%
Millennium Management LLC
0.95%
BlackRock Inc
0.89%

Analyst Recommendation on 23andme Holding Co

Buy

80%Buy

20%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for 23andme Holding Co(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on 23andme Holding Co

What analysts predicted

Upside of 887.65%

Current:

$4.05

Target:

$40.00

Insights on 23andme Holding Co

Increasing Revenue
Revenue is up for the last 2 quarters, 40.41M → 44.07M (in $), with an average increase of 8.3% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -277.97M → -59.10M (in $), with an average increase of 83.8% per quarter
Vs A
In the last 1 year, Agilent Technologies Inc. has given 7.1% return, outperforming this stock by 85.8%
Vs A
In the last 3 years, 23andme Holding Co has experienced a drawdown of -97.8%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 87.4%

23andme Holding Co Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$440.9M	-
Net Income	$-183.5M	-
Net Profit Margin	-41.63%	-

	FY20	Y/Y Change
Revenue	$305.5M	↓ 30.72%
Net Income	$-289.3M	↑ 57.63%
Net Profit Margin	-94.71%	↓ 53.08%

	FY21	Y/Y Change
Revenue	$243.9M	↓ 20.15%
Net Income	$-183.4M	↓ 36.62%
Net Profit Margin	-75.17%	↑ 19.54%

	FY22	Y/Y Change
Revenue	$271.9M	↑ 11.47%
Net Income	$-217.5M	↑ 18.61%
Net Profit Margin	-79.99%	↓ 4.82%

	FY23	Y/Y Change
Revenue	$299.5M	↑ 10.15%
Net Income	$-311.7M	↑ 43.3%
Net Profit Margin	-104.06%	↓ 24.07%

	FY24	Y/Y Change
Revenue	$219.6M	↓ 26.66%
Net Income	$-666.7M	↑ 113.92%
Net Profit Margin	-303.55%	↓ 199.49%

	Q2 FY23	Q/Q Change
Revenue	$60.9M	↓ 34.11%
Net Income	$-104.6M	↑ 63.23%
Net Profit Margin	-171.9%	↓ 102.51%

	Q3 FY23	Q/Q Change
Revenue	$50.0M	↓ 17.85%
Net Income	$-75.3M	↓ 28.06%
Net Profit Margin	-150.54%	↑ 21.36%

	Q4 FY23	Q/Q Change
Revenue	$44.7M	↓ 10.5%
Net Income	$-278.0M	↑ 269.31%
Net Profit Margin	-621.22%	↓ 470.68%

	Q1 FY24	Q/Q Change
Revenue	$64.0M	↑ 43.09%
Net Income	$-208.8M	↓ 24.87%
Net Profit Margin	-326.16%	↑ 295.06%

	Q2 FY24	Q/Q Change
Revenue	$40.4M	↓ 36.88%
Net Income	$-69.4M	↓ 66.77%
Net Profit Margin	-171.72%	↑ 154.44%

	Q3 FY24	Q/Q Change
Revenue	$44.1M	↑ 9.05%
Net Income	$-59.1M	↓ 14.84%
Net Profit Margin	-134.11%	↑ 37.61%

	FY19	Y/Y Change
Total Assets	$696.7M	-
Total Liabilities	$382.9M	-

	FY20	Y/Y Change
Total Assets	$404.6M	↓ 41.92%
Total Liabilities	$270.4M	↓ 29.37%

	FY21	Y/Y Change
Total Assets	$452.1M	↑ 11.73%
Total Liabilities	$1.0B	↑ 287.43%

	FY22	Y/Y Change
Total Assets	$1.2B	↑ 154.83%
Total Liabilities	$236.4M	↓ 77.44%

	FY23	Y/Y Change
Total Assets	$942.6M	↓ 18.18%
Total Liabilities	$228.7M	↓ 3.28%

	FY24	Y/Y Change
Total Assets	$395.2M	↓ 58.08%
Total Liabilities	$206.6M	↓ 9.63%

	Q2 FY23	Q/Q Change
Total Assets	$871.2M	↓ 7.57%
Total Liabilities	$195.7M	↓ 14.41%

	Q3 FY23	Q/Q Change
Total Assets	$801.2M	↓ 8.03%
Total Liabilities	$176.0M	↓ 10.08%

	Q4 FY23	Q/Q Change
Total Assets	$608.2M	↓ 24.09%
Total Liabilities	$231.0M	↑ 31.28%

	Q1 FY24	Q/Q Change
Total Assets	$395.2M	↓ 35.03%
Total Liabilities	$206.6M	↓ 10.55%

	Q2 FY24	Q/Q Change
Total Assets	$368.0M	↓ 6.86%
Total Liabilities	$224.5M	↑ 8.66%

	Q3 FY24	Q/Q Change
Total Assets	$318.9M	↓ 13.34%
Total Liabilities	$217.0M	↓ 3.36%

	FY19	Y/Y Change
Operating Cash Flow	$-98.1M	-
Investing Cash Flow	$-27.8M	-
Financing Cash Flow	$344.4M	-

	FY20	Y/Y Change
Operating Cash Flow	$-185.8M	↑ 89.33%
Investing Cash Flow	$-72.8M	↑ 161.58%
Financing Cash Flow	$8.8M	↓ 97.44%

	FY21	Y/Y Change
Operating Cash Flow	$-74.3M	↓ 60.03%
Investing Cash Flow	$-6.5M	↓ 91.02%
Financing Cash Flow	$155.3M	↑ 1659.17%

	FY22	Y/Y Change
Operating Cash Flow	$-166.8M	↑ 124.68%
Investing Cash Flow	$-108.1M	↑ 1554.48%
Financing Cash Flow	$546.0M	↑ 251.5%

	FY23	Y/Y Change
Operating Cash Flow	$-165.4M	↓ 0.86%
Investing Cash Flow	$-11.3M	↓ 89.55%
Financing Cash Flow	$9.8M	↓ 98.21%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-69.4M	↑ 54.26%
Investing Cash Flow	$-2.7M	↓ 18.04%
Financing Cash Flow	$-114.0K	↓ 104.37%

23andme Holding Co Technicals Summary

Sell

Neutral

Buy

23andme Holding Co is currently in a neutral trading position according to technical analysis indicators.

23andme Holding Co Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
23andme Holding Co	-22.7%	-55.2%	-78.25%	-97.84%	-63.16%
Idexx Laboratories, Inc.	-1.27%	-15.89%	-20.26%	-29.64%	69.08%
Agilent Technologies Inc.	-1.26%	3.64%	6.9%	-10.83%	66.25%
Thermo Fisher Scientific, Inc.	-6.3%	-10.43%	5.23%	-18.24%	64.26%
Danaher Corp.	-7.41%	-13.9%	2.95%	-28.63%	53.1%
Iqvia Holdings Inc.	-8.15%	-7.37%	-7.57%	-25.72%	36.83%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
23andme Holding Co	NA	NA	NA	-1.1	-1.54	-0.26	NA	7.69
Idexx Laboratories, Inc.	41.3	41.3	4.5	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	31.62	31.62	2.38	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	32.68	32.68	1.99	21.69	0.13	0.05	0.0	128.08
Danaher Corp.	42.91	42.91	3.04	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.66	26.66	1.05	11.12	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
23andme Holding Co	Buy	$82.0M	-63.16%	NA	0.0%
Idexx Laboratories, Inc.	Buy	$35.0B	69.08%	41.3	22.53%
Agilent Technologies Inc.	Buy	$40.0B	66.25%	31.62	21.75%
Thermo Fisher Scientific, Inc.	Buy	$199.2B	64.26%	32.68	14.48%
Danaher Corp.	Buy	$164.6B	53.1%	42.91	16.39%
Iqvia Holdings Inc.	Buy	$36.9B	36.83%	26.66	9.17%

About 23andme Holding Co

23andme is the leading personal genetics company dedicated to helping individuals understand their own genetic information through dna analysis technologies and web-based interactive tools. the company's personal genome service® enables individuals to gain deeper insights into their ancestry and genetic make-up. the vision for 23andme is to personalize healthcare by making and supporting meaningful discoveries through genetic research. 23andme was founded in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science.

Organization	23andme Holding Co
Employees	560
CEO	Ms. Anne Wojcicki
Industry	Financial

Management People of 23andme Holding Co

Name	Title
Ms. Anne Wojcicki	Co-Founder, CEO, President & Chair of the Board
Mr. Joseph Selsavage	Chief Financial & Accounting Officer
Mr. Eli Fry	Vice President of Operations
Mr. Guy Chayoun	VP, Interim General Counsel & Corporate Secretary
Ms. Katie Watson	Vice President of Communications
Mr. Jonathan Ward	Chief Marketing Officer
Ms. Savita Pillai	Vice President of People
Dr. Jennifer Low M.D., Ph.D.	Head of Therapeutics Development
Mr. Kent Hillyer	Vice President of Consumer Operations
Mr. Daniel Chu	Chief Product Officer

Important FAQs about investing in 23andme Holding Co from India :

What is 23andme Holding Co share price today?

23andme Holding Co (ME) share price today is $4.05.

Can Indians buy 23andme Holding Co shares?

Yes, Indians can invest in the 23andme Holding Co (ME) from India.

With INDmoney, you can buy 23andme Holding Co at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy 23andme Holding Co at zero transaction cost.

How can I buy 23andme Holding Co shares from India?

It is very easy to buy 23andme Holding Co from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of 23andme Holding Co be purchased?

Yes, you can buy fractional shares of 23andme Holding Co with INDmoney app.

What are the documents required to start investing in 23andme Holding Co stocks?

To start investing in 23andme Holding Co, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.